These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 3493285)

  • 1. Amplification of HTLV-III/LAV infection by antigen-induced activation of T cells and direct suppression by virus of lymphocyte blastogenic responses.
    Margolick JB; Volkman DJ; Folks TM; Fauci AS
    J Immunol; 1987 Mar; 138(6):1719-23. PubMed ID: 3493285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.
    McDougal JS; Mawle A; Cort SP; Nicholson JK; Cross GD; Scheppler-Campbell JA; Hicks D; Sligh J
    J Immunol; 1985 Nov; 135(5):3151-62. PubMed ID: 2995487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells.
    Ruscetti FW; Mikovits JA; Kalyanaraman VS; Overton R; Stevenson H; Stromberg K; Herberman RB; Farrar WL; Ortaldo JR
    J Immunol; 1986 May; 136(10):3619-24. PubMed ID: 2422259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro infection of human monocytes with human T lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV).
    Nicholson JK; Cross GD; Callaway CS; McDougal JS
    J Immunol; 1986 Jul; 137(1):323-9. PubMed ID: 3011909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin 2 production in HTLV-III/LAV infection: evidence of defective antigen-induced, but normal mitogen-induced IL-2 production.
    Antonen J; Krohn K
    Clin Exp Immunol; 1986 Sep; 65(3):489-96. PubMed ID: 2946497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility of normal human lymphocytes to infection with HTLV-III/LAV.
    Folks T; Kelly J; Benn S; Kinter A; Justement J; Gold J; Redfield R; Sell KW; Fauci AS
    J Immunol; 1986 Jun; 136(11):4049-53. PubMed ID: 2422271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Classification system for human T-lymphotropic virus type III/lymphadenopathy-associated virus infections.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 May; 35(20):334-9. PubMed ID: 3010072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activated T cells in addition to LAV/HTLV-III infection: a necessary precondition for development of AIDS.
    Fuchs D; Hausen A; Hoefler E; Schönitzer D; Werner ER; Dierich MP; Hengster P; Reibnegger G; Schulz T; Wachter H
    Cancer Detect Prev Suppl; 1987; 1():583-7. PubMed ID: 3500785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis--United States, 1985--and the possible impact of human T-lymphotropic virus type III/lymphadenopathy-associated virus infection.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1986 Feb; 35(5):74-6. PubMed ID: 3080659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the human T-lymphotropic virus/lymphadenopathy-associated virus on functions of human lymphocytes: evidence for immunosuppressive effects and polyclonal B-cell activation by banded viral preparations.
    Pahwa S; Pahwa R; Saxinger C; Gallo RC; Good RA
    Proc Natl Acad Sci U S A; 1985 Dec; 82(23):8198-202. PubMed ID: 2999797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunization of children infected with human T-lymphotropic virus type III/lymphadenopathy-associated virus. Recommendations of the Immunization Practices Advisory Committee. Centers for Disease Control, Department of Health and Human Services.
    Ann Intern Med; 1987 Jan; 106(1):75-8. PubMed ID: 3024547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cellular immune response in HIV(LAV/HTLV-III) infection].
    Pichler WJ
    Schweiz Med Wochenschr; 1986 Nov; 116(44):1506-13. PubMed ID: 3491423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of CD4-dependent cell fusion by the HTLV-III/LAV envelope glycoprotein.
    Lifson JD; Feinberg MB; Reyes GR; Rabin L; Banapour B; Chakrabarti S; Moss B; Wong-Staal F; Steimer KS; Engleman EG
    Nature; 1986 Oct 23-29; 323(6090):725-8. PubMed ID: 3095663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Sodroski J; Goh WC; Rosen C; Campbell K; Haseltine WA
    Nature; 1986 Jul 31-Aug 6; 322(6078):470-4. PubMed ID: 3016552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro induction of HIV-1 replication in resting CD4(+) T cells derived from individuals with undetectable plasma viremia upon stimulation with human T-cell leukemia virus type I.
    Moriuchi H; Moriuchi M
    Virology; 2000 Dec; 278(2):514-9. PubMed ID: 11118373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virologic studies of HTLV-III/LAV in pregnancy: case report of a woman with AIDS.
    Rogers MF; Ewing EP; Warfield D; Hardy AM; Emery DR; Wolf GC
    Obstet Gynecol; 1986 Sep; 68(3 Suppl):2S-6S. PubMed ID: 3016628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of immune responses by dendritic cells infected with HIV.
    Macatonia SE; Patterson S; Knight SC
    Immunology; 1989 Jul; 67(3):285-9. PubMed ID: 2788124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.